Harel Insurance Investments & Financial Services Ltd. Capricor Therapeutics, Inc. Call Options Transaction History
Harel Insurance Investments & Financial Services Ltd.
- $5.16 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CAPR
# of Institutions
62Shares Held
4.74MCall Options Held
123KPut Options Held
53.8K-
Vanguard Group Inc Valley Forge, PA1.37MShares$6.57 Million0.0% of portfolio
-
Black Rock Inc. New York, NY382KShares$1.84 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA328KShares$1.58 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA316KShares$1.52 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny293KShares$1.41 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $117M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...